Black Diamond Therapeutics, Inc. - Common Stock (BDTX)

Historical Holders from Q1 2020 to Q3 2025

Symbol
BDTX on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
56.1M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
38.8M
Holdings value
$147M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
89
Number of buys
49
Number of sells
-45
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Black Diamond Therapeutics, Inc. - Common Stock (BDTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BB BIOTECH AG 4.8% -68.7% $4.37M -$9.25M 2.73M -67.9% BB Biotech AG 19 Mar 2025
BlackRock, Inc. 4.5% $4.04M 2.52M BlackRock, Inc. 31 Mar 2025

Institutional Holders of Black Diamond Therapeutics, Inc. - Common Stock (BDTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 38.8M $147M +$5.64M $3.79 89
2025 Q2 38.6M $95.8M -$4.38M $2.48 92
2025 Q1 40.7M $63M -$11.8M $1.55 83
2024 Q4 47.9M $103M -$13.8M $2.14 85
2024 Q3 48.7M $212M +$1.57M $4.35 95
2024 Q2 46.8M $218M +$31.7M $4.66 88
2024 Q1 39.4M $200M +$10.7M $5.07 86
2023 Q4 38.1M $107M +$4.41M $2.81 73
2023 Q3 37.2M $107M -$21.9M $2.87 71
2023 Q2 41.4M $209M +$105M $5.05 72
2023 Q1 21.5M $40.6M +$847K $1.89 47
2022 Q4 21.1M $37.9M -$722K $1.80 56
2022 Q3 21.5M $36.3M -$285K $1.69 57
2022 Q2 21.5M $52.9M -$3.55M $2.46 56
2022 Q1 22.9M $64.1M -$2.43M $2.77 69
2021 Q4 23.2M $124M -$13M $5.33 83
2021 Q3 24.4M $206M -$11.2M $8.46 89
2021 Q2 25.4M $310M -$81.4M $12.19 97
2021 Q1 29.1M $706M -$7.56M $24.26 109
2020 Q4 28.6M $917M +$140M $32.05 109
2020 Q3 23.8M $718M +$754K $30.23 88
2020 Q2 22.8M $959M +$39.9M $42.16 79
2020 Q1 22.3M $555M +$555M $24.95 65